Publication | Closed Access
SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated.
23
Citations
0
References
2011
Year
These results suggest that SLIT2 is a tumor suppressor in ovarian cancer, and may be a novel target for ovarian cancer treatment.